+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid reduces mucin concentration in the gallbladder bile of patients with gallstones



Ursodeoxycholic acid reduces mucin concentration in the gallbladder bile of patients with gallstones



Gastroenterology 108(4 Suppl. ): A1169




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144892

Download citation: RISBibTeXText


Related references

Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones. European Journal of Clinical Investigation 38(9): 634-639, 2008

Ursodeoxycholic acid decreases viscosity and sedimentable fractions of gallbladder bile in patients with cholesterol gallstones. European Journal of Gastroenterology and Hepatology 16(3): 305-311, 2004

Gallbladder mucin, arachidonic acid, and bile lipids in patients who develop gallstones during weight reduction. Gastroenterology 105(4): 1200-1208, 1993

Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones. Journal of Hepatology 8(1): 1-6, 1989

Prolonged cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones under treatment with low dose ursodeoxycholic acid. Gastroenterology 92(5 Part 2): 1742, 1987

Effect of gallstones and bile acid ba treatment on gallbladder motility a crossover study with chenodeoxycholic and ursodeoxycholic acid. Journal of Hepatology 9(Suppl. 1): S238, 1989

Ursodeoxycholic acid reduces protein levels and their nucleation promoting activity in gallbladder bile of cholesterol stone patients. Hepatology 22(4 Part 2): 504A, 1995

Influence of ursodeoxycholic acid urso on fasting gallbladder volume and gallbladder emptying in patients with cholesterol gallstones and controls. Gastroenterology 94(5 Part 2): A603, 1988

Mucin and phospholipids determine viscosity of gallbladder bile in patients with gallstones. World Journal of Gastroenterology 7(2): 203-207, 2002

Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones. Tokai Journal of Experimental and Clinical Medicine 7(6): 671-683, 1982

Effect of ursodeoxycholic Acid alone and ursodeoxycholic Acid plus domperidone on radiolucent gallstones and gallbladder contractility in humans. Gastroenterology Research and Practice 2012: 159438, 2012

Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity of human bile in cholesterol gallstone disease. Gastroenterology 114(4 Part 2): A548-A549, April 15, 1998

Ursodeoxycholic acid reduces protein levels and nucleation-promoting activity in human gallbladder bile. Gastroenterology 110(4): 1225-1237, 1996

Effects of ursodeoxycholic acid therapy on in vitro gallbladder contractility in patients with cholesterol gallstones. Digestive Diseases & Sciences 44(1): 190-196, 1999

The immunoglobulin concentration of human gallbladder bile patients with and without gallstones. Gastroenterology 100(5 Part 2): A751, 1991